Clinical Responses in Patients with Inadequate Response to bDMARDs upon Treatment with Upadacitinib

被引：0

作者：

Weinblatt, Michael ^{[1
]}

Thomson, Glen ^{[2
]}

Chen, Kun ^{[3
]}

Meerwein, Sebastian ^{[4
]}

Schlacher, Casey ^{[3
]}

Cush, John ^{[5
]}

机构：

[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[2] CIADS Res, Winnipeg, MB, Canada

[3] AbbVie Inc, N Chicago, IL USA

[4] AbbVie GmbH Co KG, Ludwigshafen, Germany

[5] Baylor Univ, Med Ctr, Dallas, TX USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0515

引用

页数：3

共 50 条

[21] Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks
Smolen, Josef
Emery, Paul
Rigby, William
Tanaka, Yoshiya
Vargas, Juan
Damjanov, Nemanja
Jain, Manish
Song, Yanna
Khan, Nasser
Enejosa, Jeffrey
Cohen, Stanley
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[22] BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF TOFACITINIB FOR TREATMENT OF PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS, IN PATIENTS WHO HAVE AN INADEQUATE RESPONSE TO CSDMARDS AND ARE REFRACTORY TO BDMARDS IN ALGERIA
Nouaoui, A. A.
Derki, S.
Enzrati, Jalal J.
Ling, Y. L.
VALUE IN HEALTH, 2024, 27 (12) : S88 - S88
[23] The Clinical Response of Upadacitinib and Risankizumab Is Associated With Reduced Inflammatory Bowel Disease Anti-TNF-α Inadequate Response Mechanisms
Wang, Jing
Macoritto, Michael
Guay, Heath
Davis, Justin W.
Levesque, Marc C.
Cao, Xiaohong
INFLAMMATORY BOWEL DISEASES, 2023, 29 (05) : 771 - 782
[24] Effect of Inadequate Response to Treatment in Patients With Depression
Knoth, Russell L.
Bolge, Susan C.
Kim, Edward
Tran, Quynh-Van
AMERICAN JOURNAL OF MANAGED CARE, 2010, 16 (08): : E188 - E196
[25] Association Between Short-Term Response to Upadacitinib Treatment and Long-Term Clinical Outcomes in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy
Charles-Schoeman, Christina
Fleischmann, Roy
Hall, Stephen
Kavanaugh, Arthur
Rubbert-Roth, Andrea
DeMasi, Ryan
Penn, Sara
Garrison, Andrew
Anyanwu, Samuel
Sierra-Zorita, Radames
Xavier, Ricardo
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 551 - 552
[26] Impact of Upadacitinib versus Abatacept on Individual Disease Outcomes in Patients with Rheumatoid Arthritis and Inadequate Responses to Biologic DMARDs
van Vollenhoven, Ronald
Rubbert-Roth, Andrea
Hall, Stephen
Xavier, Ricardo
Shmagel, Anna K.
Song, Yanna
Anyanwu, Samuel
Strand, Vibeke
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2812 - 2814
[27] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
Kavanaugh, Arthur
Buch, Maya
Combe, Bernard
Bessette, Louis
Song, In-Ho
Song, Yanna
Suboticki, Jessica
Nash, Peter
INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 46
[28] Sustainability of Response to Upadacitinib as Monotherapy or in Combination Among Patients with Rheumatoid Arthritis and Prior Inadequate Response to Conventional Synthetic DMARDs
Kavanaugh, Arthur
Buch, Maya
Combe, Bernard
Bessette, Louis
Song, In-Ho
Song, Yanna
Suboticki, Jessica
Nash, Peter
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[29] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AS MONOTHERAPY OR IN COMBINATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS
Kavanaugh, A.
Buch, M. H.
Combe, B.
Bessette, L.
Song, I. H.
Song, Y.
Suboticki, J.
Nash, P.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 323 - 324
[30] Upadacitinib Monotherapy Improves Patient-Reported Outcomes in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate
Strand, Vibeke
Buch, Maya
Tundia, Namita
Camp, Heidi S.
Suboticki, Jessica
Goldschmidt, Debbie
Wells, Alvin F.
ARTHRITIS & RHEUMATOLOGY, 2018, 70

← 1 2 3 4 5 →